The Boao Lecheng International Medical Tourism Pilot Zone – China’s only district allowed to import unapproved foreign pharmaceuticals and devices – has opened a comprehensive one-stop services centre aimed squarely at overseas patients. The facility, inaugurated on 3 June, collocates immigration desks, hospital liaisons, travel agencies and multilingual concierges so that visitors can arrange visas, airport transfers, treatment scheduling and post-operative leisure in a single sitting. Zone administrators said the desk will link more than 40 hospitals and research institutes through a real-time referral platform so that foreign doctors can upload case files in advance, cutting pre-admission waiting times by 30 %.
![Hainan’s Boao Lecheng pilot zone launches one-stop desk for foreign medical tourists]()
For travellers who still need formal documentation or simply want expert help navigating China’s evolving entry rules, VisaHQ can take the legwork out of the process. Its dedicated China portal (https://www.visahq.com/china/) walks applicants through medical-visa requirements, assembles supporting letters from admitting hospitals, and submits packets to consulates on an expedited timetable—freeing patients and corporate mobility teams to focus on care rather than paperwork.
A newly introduced "service-officer system" assigns each patient a dedicated coordinator from arrival to departure – an approach borrowed from Singapore’s medical corridors but rare on the Chinese mainland. Lecheng’s upgrade rides on Hainan’s liberal 59-country visa-free regime, now effectively expanded to 86 markets once mutual- and unilateral-waiver deals are included. Patients entering under the waiver can stay up to 30 days, extendable to six months if the admitting hospital files a medical-necessity request – a flexibility that oncology and fertility specialists say is critical for multi-stage therapies. Officials are also piloting biometric e-gates at Haikou’s new cruise terminal so that recovering patients can depart the island without queuing at manual booths. Medical travel is already big business for Hainan. The zone handled nearly 10,000 international patient visits in 2025 and 4,000 in the first four months of 2026, with Russians, Canadians and Gulf nationals topping the list. More than 570 "early-access" drugs and devices have been introduced since 2019, including cutting-edge boron neutron-capture therapy showcased last month when a Russian cancer patient combined treatment with a beach holiday in Qionghai. For HR and global mobility managers, the message is twofold: corporate insurance plans can now route employees to Lecheng without the administrative friction typically associated with mainland hospital stays; and expatriates already based in China can leverage direct-billing arrangements negotiated with several Fortune 500 insurers. Travel teams should update internal guidance to flag Hainan as a visa-light option for elective and high-end medical care.
For travellers who still need formal documentation or simply want expert help navigating China’s evolving entry rules, VisaHQ can take the legwork out of the process. Its dedicated China portal (https://www.visahq.com/china/) walks applicants through medical-visa requirements, assembles supporting letters from admitting hospitals, and submits packets to consulates on an expedited timetable—freeing patients and corporate mobility teams to focus on care rather than paperwork.
A newly introduced "service-officer system" assigns each patient a dedicated coordinator from arrival to departure – an approach borrowed from Singapore’s medical corridors but rare on the Chinese mainland. Lecheng’s upgrade rides on Hainan’s liberal 59-country visa-free regime, now effectively expanded to 86 markets once mutual- and unilateral-waiver deals are included. Patients entering under the waiver can stay up to 30 days, extendable to six months if the admitting hospital files a medical-necessity request – a flexibility that oncology and fertility specialists say is critical for multi-stage therapies. Officials are also piloting biometric e-gates at Haikou’s new cruise terminal so that recovering patients can depart the island without queuing at manual booths. Medical travel is already big business for Hainan. The zone handled nearly 10,000 international patient visits in 2025 and 4,000 in the first four months of 2026, with Russians, Canadians and Gulf nationals topping the list. More than 570 "early-access" drugs and devices have been introduced since 2019, including cutting-edge boron neutron-capture therapy showcased last month when a Russian cancer patient combined treatment with a beach holiday in Qionghai. For HR and global mobility managers, the message is twofold: corporate insurance plans can now route employees to Lecheng without the administrative friction typically associated with mainland hospital stays; and expatriates already based in China can leverage direct-billing arrangements negotiated with several Fortune 500 insurers. Travel teams should update internal guidance to flag Hainan as a visa-light option for elective and high-end medical care.
